Health tech firm Heydoc has raised £6.1m in series A funding to drive its UK growth and expand its product range.
Haydoc has developed an integrated clinical operating system and electronic health record (EHR).
The new funding will fuel expansion in the UK healthcare market and internationally beyond the firm’s current international footprint.
The bulk of the raise will be used to grow the team which currently stands at 30 employees.
Heydoc’s mission is to improve healthcare by “empowering clinical team with an all-encompassing operating system”.
Its software aims to solve core workflow issues for clinicians, improving the user and patient experience – and providing a “vastly improved offering compared to existing legacy solutions”.
The system provides features for clinicians and support staff covering medical and administrative tasks.
Heydoc also connects its clinic customers with various other healthcare providers, such as hospital groups, pathology services, pharmacies, to enable “data liquidity” and address the lack of system interoperability.
Heydoc, which went live in 2018, was co-founded by entrepreneurs Christoph Lippuner and Mikael Landau.
Lippuner, who serves as CEO, said: “This new raise will help us accelerate our growth in the UK, focus on our product and expand its capabilities, as well as go after international markets.
“Innovating and contributing to a transforming healthcare industry, profoundly impacted by regulatory changes, new patient expectations and a global pandemic, is both fascinating and rewarding. There is so much to be done in this industry and Heydoc is barely scratching the surface.”
The new investment round was led by Smedvig Capital with existing investors Hambro Perks, Triple Point Ventures and InHealth Ventures also participating.
This brings the total amount raised to date by Heydoc to £8.9m (US$12m).
Jon Lerner, MD at Smedvig, said: “We are delighted to invest in Heydoc and partner with Christoph and Mikael. Heydoc has grown rapidly and proven that its platform can dramatically improve the way clinicians work and the quality of patient interaction.
“The company has a strong mission-based culture and a huge opportunity in front of them to be part of the future of healthcare. We’re looking forward to supporting them in achieving this goal.”
